Immunotherapy for multiple sclerosis.
Hughes
R A
RA
D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005544:Forecasting; D006801:Humans; D007167:Immunotherapy / Q000639:trends; D016899:Interferon-beta / Q000627:therapeutic use; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000628:therapy*; D012008:Recurrence
D016899:Interferon-beta; D016572:Cyclosporine; D003520:Cyclophosphamide; D001379:Azathioprine